BioSpace News Archive

Business

Terns Pharmaceuticals Appoints Kerry Russell as Chief Medical Officer

Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), today announced the appointment of Kerry Russell, M.D., Ph.D., as chief medical officer.

June 1, 2022
·
6 min read
Biotech Bay

DICE Therapeutics to Present at the 2022 Jefferies Healthcare Conference

DICE Therapeutics, Inc. announced that management will present at the Jefferies Healthcare Conference on Thursday, June 9, 2022 at 2:30 p.m. ET.

June 1, 2022
·
1 min read
Smart Healthcare Market Size, Share, Growth, Trends, Forecast Report 2021 to 2030

According to Vision Research Reports, the smart healthcare market growth is expected to reach at a CAGR of 17.2% during forecast period 2021 to 2030 and to attain valuation US$ 550.9 billion by 2030.

June 1, 2022
·
4 min read
Deals

Oracle Purchase of Cerner Approved

Oracle Corporation announced that all required antitrust approvals have been obtained for its proposed acquisition of Cerner, including European Commission clearance.

June 1, 2022
·
7 min read
Genetown

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 01, 2022

Karyopharm Therapeutics Inc. announced that the Company approved the grant of stock options to purchase an aggregate of 136,700 shares of Karyopharm’s common stock and an aggregate of 90,700 restricted stock units to 18 newly-hired employees.

June 1, 2022
·
2 min read
Biotech Bay

Protagonist Therapeutics to Participate at the Jefferies Healthcare Conference - June 01, 2022

Protagonist Therapeutics, Inc. announced that Dinesh V. Patel, Ph.D., President, and Chief Executive Officer, will present at the Jefferies Healthcare Conference in New York on Wednesday, June 8 at 9:30 a.m. ET.

June 1, 2022
·
2 min read
Biotech Beach

MEI Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - June 01, 2022

MEI Pharma, Inc., a late-stage pharmaceutical company focused on advancing new therapies for cancer, announced the grant of inducement stock options for an aggregate of 40,000 shares of the company’s common stock to one new employee.

June 1, 2022
·
4 min read
Lone Star Bio

Savara to Present at Jefferies Healthcare Conference - June 01, 2022

Savara Inc., a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced that its management team will present at the Jefferies Healthcare Conference on June 8, 2022 at 1:00 pm ET in New York City.

June 1, 2022
·
1 min read
Biotech Bay

Spruce Biosciences to Participate in June 2022 Investor Conferences

Spruce Biosciences, Inc. announced that company management will participate in two upcoming investor conferences taking place in June.

June 1, 2022
·
1 min read
Genetown

Radius Health Update on Abaloparatide Transdermal System

Radius Health, Inc. (“Radius” or the “Company”) (NASDAQ: RDUS) provided an update on the abaloparatide transdermal system (abalo-TDS) development program.

June 1, 2022
·
6 min read